Nano PharmaSolutions
San Diego
About Nano PharmaSolutions
Nano PharmaSolutions improves the bioavailability of insoluble drugs using innovative, revolutionary nanoformulation. Nano PharmaSolutions offers a phase-transition technology platform that can reliably enhance the solubility of BCS 2 and BCS 4 APIs without the use of excipients (e.g. large volumes of volatile solvents) used in such processes as spray dry dispersion, hot-melt extrusion, and emulsification. Their patented technology platform deposits vaporized API onto the surface of a carrier molecule which is further processable into the full spectrum of existing dosage forms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $331.0K
- Funding stage: Seed
- Last round: Seed (Feb 2023)
- Website: nanopharmasolutions.com
- Phone: (858) 208-8419
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nano-pharmasolutions-17261 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.